The Synera Expert Advisory Board

---

Managing Partner 

Convergence Health Capital

Founder 

Nexus Health Alliance

Founder

Kairos Accelerator

Jordan Morrison is a healthcare innovation strategist, ecosystem builder, and commercialization executive focused on advancing promising technologies from concept to patient bedside. 

As Founder and Principal of Synera Advisory, she leads a physician-backed advisory platform that integrates clinical intelligence, regulatory strategy, commercialization, strategic partnerships, and capital readiness to help healthcare innovators reduce risk and build scalable companies.

She also seres as Managing Partner of Convergence Health Capital, a physician-informed Medtech investment platform supporting early-stage healthcare technologies through disciplined diligence, strategic guidance, and aligned capital.

As founder of Nexus Health Alliance Jordan is building a collaborative network of physicians, healthcare organizations, and industry partners designed to strengthen independent healthcare, expand access to innovation, and create new opportunities for true evidence based and value based care.

Through Kairos Medtech Accelerator, she leads an intensive launch program that helps founders validate their strategy, address critical commercialization gaps, and build the infrastructure needed to move decisively toward funding, market entry, and adoption.

Across each organization, Jordan's work is guided by one principal: innovation creates meaningful impact only when it successfully reaches the patient.

Mike Mayszak is a strategic product and commercialization executive with more than 20 years of experience bringing complex technologies to market.

At Synera Advisory, Mike strengthens our commercialization ecosystem by helping founders translate innovative ideas into market-ready solutions through product strategy, go-to-market execution, channel development, and business growth. His enterprise leadership across fortune 500 organizations enable Synera clients to build scalable products, align with customer needs, and accelerate sustainable commercial success.

Founder Kairos Accelerator

CEO Hands Associates

Hakeem Adebiyi is a global MedTech commercialization executive specializing in international market expansion, distribution strategy, and cross-border growth. 

As Founder and Principal of Kairos Accelerator and CEO of Hands Associates, he has helped healthcare innovators successfully navigate complex global markets through proven commercialization frameworks, strategic partnerships, and scalable market entry strategies.

Within the Synera ecosystem, Hakeem extends our physician-led commercialization platform beyond the US by helping founders identify international growth opportunities, develop global-go-to-market strategies, build high value distribution networks, and execute market expansion across Europe, the UK, and other emerging healthcare markets. Heis expertise ensures  commercialization strategies are aligned with regulatory pathways, reimbursement realities, channel development,, and sustainable international growth.

Founder and CEO Trivent Medical 

Managing Partner 

Convergence Health Capital

Casey Barton is a Certified Registered Nurse Anesthetist (CRNA), medical device innovator, and healthcare entrepreneur with more than 15 years of frontline clinical experience in anesthesia, airway management, and perioperative patient safety. His experience inspired the development of Trivent Medical, a patented airway management platform designed to improve patient safety and clinical outcomes. As Founder and CEO of Trivent Medical, Casey combines clinical expertise with product innovation to address unmet needs in airway management.

Within the Synera ecosystem, Casey represents the clinician-founder partnering with Synera to commercialize Trivent Medical while contributing practical insight into product development, regulatory strategy, and market adoption. As General Partner of Convergence Health Capital, he also helps identify and support transformative healthcare innovations with strong clinical and commercial potential.

Rob Matzkin is an enterprise growth executive with extensive experience scaling technology companies through commercialization, revenue strategy, and operational leadership. As a former CEO, CRO, investor and advisor, he specializes in building high-performing go-to-market organizations and guiding companies through growth, fundraising and strategic partnerships.

At Synera Advisory, Rob leads commercialization strategy and enterprise growth initiatives, helping founders develop scalable revenue models, strengthen market positioning, and execute successful go to-to-market strategies. His expertise bridges innovation and commercial execution, ensuring breakthrough healthcare technologies are built to achieve sustainable market success.

David Pennington, RN, BSN, MBA is a healthcare executive with extensive experience scaling MedTech and life science companies through commercialization, strategic growth, and executive leadership. With a track record spanning multiple successful exits, global sales leadership, and board advisory roles, he specializes in transforming innovative technologies into market leading businesses.

At Synera Advisory, David leads commercialization strategy and market expansion iniitatives, leveraging his clinical background and executive expertise to help founders build high-performing commercial organizations, establish strategic partnerships, and accelerate adoption of breakthrough healthcare innovations. His experience compliments Synera's physician-backed ecosystem by ensuring exceptional technologies achieve lasting commercial success.

Chad Zoretic is a nationally recognized healthcare transaction and strategy executive specializing in mergers and acquisitions, capital strategy, and enterprise value creation. With decades of experience advising healthcare providers, digital health innovators medical device companies, and private equity investors, he helps organizations maximize growth through disciplined financial strategy and transaction execution.

At Synera Advisory, Chad provides executive guidance on strategic partnerships, capital planning due diligence. and exit readiness. His expertise compliments Synera's  physician-backed commercialization platform by helping innovative healthcare companies become investment ready, execute strategic transactions, and create lasting enterprise value.

Chris Danek is a MedTech executive, entrepreneur, and strategic advisor with more than 20 years of experience building and scaling medical device companies. A Stanford PHD and Wharton MBA, Chris has led breakthrough technologies through development, FDA approval, commercialization, capital formation, and acquisition, contributing to three nine-figure exits. At Synera, he brings seasoned executive leadership across venture strategy, capital efficiency, organizational scale, and value creation, helping companies navigate critical inflection points from innovation through exit.

David Pudwill is one of Synera Advisory's Strategic Regulatory Partners, bringing nearly two decades of FDA and medical device leadership across regulatory affairs, quality systems, and clinical strategy.

As a former FDA reviewer and Fractional Chief Regulatory Officer, David helps innovators navigate complex global regulatory pathways, de-risk product development, and build submission strategies that accelerate commercialization. His expertise strengthens Synera's physician-led ecosystem by ensuring regulatory strategy is aligned with clinical evidence, reimbursement, investor readiness, and successful market adoption from concept through commercialization.

Brooke Haddock is a clinical research and regulatory affairs strategist with more than 20+ years of experience spanning therapeutic development, clinical evidence, regulatory strategy, data analytics, and research operations.

As CEO of Data Discern Bridges and an instructor and capstone mentor in Regulatory Affairs at San Diego State University, Brooke brings a rare combination of academic rigor, regulatory intelligence, and practical industry execution to complex healthcare innovation.

At Synera Advisory, Brooke strengthens our clinical and regulatory intelligence capabilities by helping innovators translate data into defensible evidence, align clinical development with regulatory strategy, and identify critical gaps before they become barriers to commercialization. Her expertise across clinical trial strategy, regulatory reporting,  evidence generation, and data-driven decision making help ensure that product development is bult around evidence capable of supporting regulatory approval, clinical adoption, and long term market success. 

Craig Coombs is a senior medical device regulatory executive with nearly four decades of experience spanning regulatory affairs, clinical strategy, quality assurance, and global product development.

 A former Vice President of Regulatory, Clinical Affairs, and Quality Assurance within Medtronic and longtime independent regulatory consultant, Craig has guided medical technologies across the U.S, European, and Asian regulatory pathways.

At Synera, he brings deep executive-level expertise in regulatory strategy, clinical development, and risk mitigation to accelerate complex medical technologies from development through market authroization.

Latoya is a technology and cybersecurity executive with extensive experience spanning enterprise IT, digital infrastructure, computer forensics, healthcare compliance, and organizational transformation. 

A former Director of Information Technology and Computer Forensics for the Illinois Office of Executive Inspector General and current technology executive and educator, Latoya brings deep expertise in secure, scalable technology environments. 

At Synera, she leads strategic technology and cybersecurity initiatives, strengthening digital infrastructure, HIPAA compliance, data governance, and enterprise readiness across healthcare organizations and emerging technologies.